Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 4

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Dermatologic 4Head & Neck 1Genitourinary 1Endocrine 1

Conditions

Neoplasms 43Breast Neoplasms 31Prostatic Neoplasms 27Colorectal Neoplasms 26Lung Neoplasms 17Hematopoietic and Lymphatic System Neoplasm 12Ovarian Neoplasms 11Hematologic Neoplasms 11Uterine Cervical Neoplasms 7Multiple Myeloma 7Lymphoma 7Leukemia 7Head and Neck Neoplasms 6Endometrial Neoplasms 6Depression 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Pancreatic Neoplasms 5Leukemia, Myeloid, Acute 5Urinary Bladder Neoplasms 4Rectal Neoplasms 4Mouth Neoplasms 4Motor Activity 4Melanoma 4Hematopoietic and Lymphoid System Neoplasm 4Gastrointestinal Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Anxiety Disorders 4Advanced Cancer 4Triple Negative Breast Neoplasms 3Stomach Neoplasms 3

Interventions

Nivolumab 146Ipilimumab 137pembrolizumab 122Cyclophosphamide 78Interleukin-2 69aldesleukin 63Temozolomide 46trametinib 37Radiosurgery 37Vemurafenib 36fludarabine 34Biopsy 34dabrafenib 33Radiotherapy 33Blood Specimen Collection 31fludarabine phosphate 30sargramostim 27Bevacizumab 27Introns 23Dacarbazine 22Magnetic Resonance Spectroscopy 21CTLA-4 Antigen 20encorafenib 19cobimetinib 19binimetinib 19Specimen Handling 19Paclitaxel 19Granulocyte-Macrophage Colony-Stimulating Factor 19Cisplatin 17incomplete Freund's adjuvant 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Melanoma × Interviews as Topic × Clear all
NCT04751396 2026-05-20

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

M.D. Anderson Cancer Center

Recruiting
125 enrolled
Dermatologic

Arthritis, Rheumatoid, Autoimmune Diseases, Colitis, Ulcerative, Crohn Disease, Lupus Erythematosus, Systemic, Melanoma, Psoriasis, Spondylitis, Ankylosing, Inflammatory Bowel Diseases, Arthritis, Psoriatic, Arthritis, Reactive

NCT07529080 2026-04-14

Personalized Cancer Support (Thrive Track) to Manage the Emotional Needs of Young Adults With Thyroid, Melanoma and Testicular Cancer, PerCS-YA Trial

University of Michigan Rogel Cancer Center

Phase NA Not yet recruiting
142 enrolled
DermatologicEndocrineGenitourinaryHead & Neck

Thyroid Cancer, Papillary, Melanoma, Testicular Neoplasms, Adenocarcinoma, Follicular

NCT00510302 2020-09-16

Melanoma Risk-Reduction Among Patients and Family Members

M.D. Anderson Cancer Center

Completed
170 enrolled
Dermatologic

Melanoma

NCT00394134 2019-09-13

Targeted Intervention for Melanoma Prevention

M.D. Anderson Cancer Center

Phase NA Completed
205 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡